TherapeuticsMD (TXMD) Insider Trading & Ownership $1.03 0.00 (0.00%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TherapeuticsMD (NASDAQ:TXMD) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.30%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$2,040.00Number OfInsiders Selling(Last 12 Months)0 Get TXMD Insider Trade Alerts Want to know when executives and insiders are buying or selling TherapeuticsMD stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TXMD Insider Buying and Selling by Quarter TherapeuticsMD Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/21/2024Cooper C CollinsDirectorBuy1,200$1.70$2,040.00 (Data available from 1/1/2013 forward) TXMD Insider Trading Activity - Frequently Asked Questions Who is on TherapeuticsMD's Insider Roster? The list of insiders at TherapeuticsMD includes Brian Bernick, Cooper C Collins, Gail K. Naughton, Marlan D Walker, Michael C Donegan, and Rubric Capital Management Lp. Learn more on insiders at TXMD. What percentage of TherapeuticsMD stock is owned by insiders? 2.30% of TherapeuticsMD stock is owned by insiders. Learn more on TXMD's insider holdings. Which TherapeuticsMD insiders have been buying company stock? The following insider purchased TXMD shares in the last 24 months: Cooper C Collins ($2,040.00). How much insider buying is happening at TherapeuticsMD? Insiders have purchased a total of 1,200 TXMD shares in the last 24 months for a total of $2,040.00 bought. Which TherapeuticsMD insiders have been selling company stock? The following insider sold TXMD shares in the last 24 months: Marlan D Walker ($37,765.50). How much insider selling is happening at TherapeuticsMD? Insiders have sold a total of 15,670 TherapeuticsMD shares in the last 24 months for a total of $37,765.50 sold. TherapeuticsMD Key ExecutivesGovernor Thomas G. Thompson (Age 82)Executive Chairman Compensation: $160kMr. Marlan D. Walker J.D. (Age 49)Chief Executive Officer Compensation: $661.42kMr. Joseph A. Ziegler (Age 50)Principal Financial & Accounting Officer Compensation: $84.64kMr. Robert G. Finizio (Age 53)Co-Founder Compensation: $7.51kMr. Douglas SteelmanVice President of Market Access More Insider Trading Tools from MarketBeat Related Companies Aileron Therapeutics Insider Trades Ovid Therapeutics Insider Trades Nabriva Therapeutics Insider Trades SCYNEXIS Insider Trades Kezar Life Sciences Insider Trades PepGen Insider Trades Spero Therapeutics Insider Trades OS Therapies Insider Trades RAPT Therapeutics Insider Trades MiNK Therapeutics Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles META Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying3 Stocks With Strong Capital Returns and Insider Buying Signals This page (NASDAQ:TXMD) was last updated on 2/14/2025 by MarketBeat.com Staff From Our Partners*Breaking News!* This Pharma NASDAQ Company and the U.S Army!!! This Little Known NASDAQ Company just released positive results from its drugs that have been undergoing testi...Trading Wire | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredCentral Bank Abandons USDWarren Buffett Dumping Stocks at Record Levels… Discover how savvy Americans are positioning their retireme...True Gold Republic | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredElon’s #1 investment during Trump’s termWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredMarket down? Do this now.The Trump administration's new tariffs have already begun to shake the economy. The impact is real, and the cl...Colonial Metals | SponsoredMust-See: Trump’s Shocking AI AnnouncementIf you have any investments in AI stocks or are interested in AI… Please take a moment to review the detail...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TherapeuticsMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TherapeuticsMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.